Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
MEGMILK SNOW BRAND CO LTD	SAPPORO-SHI HOKKAIDO 0650043

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....

• 2011 Application Filing Year
• A61K Class
• 10915 Applications Filed
• 8360 Patents Issued To-Date
• 76.60 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
HIGURASHI, Satoshi	Saitama, JP	15	46
# of filed Patents : 15 Total Citations : 46
KAWAKAMI, Hiroshi	Saitama, JP	261	7016
# of filed Patents : 261 Total Citations : 7016
MATSUYAMA, Hiroaki	Saitama, JP	74	1486
# of filed Patents : 74 Total Citations : 1486

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 1 Citation Count
• A61K Class

• 10.68 % this patent is cited more than
• 14 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2011/0171,317

METHOD FOR INHIBITING ACCUMULATION OF VISCERAL FAT

---

Abstract

---

Disclosed is: a visceral fat accumulation inhibitor or a food or drink for inhibiting the accumulation of a visceral fat, which composes a fat globule membrane component as an active ingredient; or a agent or food or drink for promoting the increase in the blood adiponection level and/or inhibiting the decrease in the blood adiponection level, which composes a fat globule membrane component as an active ingredient. A fat globule membrane component can inhibit the accumulation of a visceral fat, and/or can promote the increase in or inhibit the decrease in the blood adiponection level.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.